EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Procalcitonin and C‐reactive protein as early markers of anastomotic leakage in intestinal resections for advanced ovarian cancer ( EDMOCS )

José Luis Sánchez-Iglesias iD, Clara Morales-Coma, Lucas Minig, Víctor Lago iD, Santiago Domingo, Gemma Mancebo, Jaime Siegrist, María Soledad Fidalgo García, Antoni Llueca iD, Anna Serra, Paloma Cobas Lozano, Arantza Lekuona Artola und 7 weitere

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14834 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von José Luis Sánchez-Iglesias und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: Anastomotic Leak, C-Reactive Protein, Ovarian Neoplasms, Procalcitonin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Institut de Recerca Hospital Universitari Vall d’Hebron.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Serum levels of procalcitonin and C‐reactive protein (CRP) have been used to predict anastomotic leakage after colorectal surgery, but information is scarce in advanced ovarian cancer (AOC) surgery with bowel resection. This study aimed to assess the predictive value of procalcitonin and CRP in detecting anastomotic leakage after AOC surgery with bowel resection. The study also aimed to determine the optimal postoperative reference values and the best day for evaluating these markers. Material and methods This prospective, observational and multicentric trial included 92 patients with AOC undergoing debulking surgery with bowel resection between 2017 and 2020 in 10 reference hospitals in Spain. Procalcitonin and CRP levels were measured at baseline and on postoperative days 1–6. Receiver operating characteristic analysis was performed to evaluate the predictive value of procalcitonin and CRP at each postoperative day. Sensitivity, specificity, positive and negative predictive values were calculated.

Results

Anastomotic leakage was detected in six patients (6.5%). Procalcitonin and CRP values were consistently higher in patients with anastomotic leakage at all postoperative days. The maximum area under the curve (AUC) for procalcitonin was observed at postoperative day 1 (AUC = 0.823) with a cutoff value of 3.8 ng/mL (83.3% sensitivity, 81.3% specificity). For CRP, the maximum AUC was found at postoperative day 3 (AUC = 0.833) with a cutoff level of 30.5 mg/dL (100% sensitivity, 80.4% specificity).

Conclusions

Procalcitonin and C‐reactive protein are potential biomarkers for early detection of anastomotic leakage after ovarian cancer surgery with bowel resection. Further prospective studies with a larger sample size are needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anastomotic LeakC-Reactive ProteinOvarian NeoplasmsProcalcitoninHumansFemaleProspective StudiesMiddle AgedAgedPredictive Value of TestsBiomarkersAdultSpainBiomarkers, TumorCytoreduction Surgical Procedures

Stichwörter der Autor:innen

anastomotic leakagecolorectal resectionovarian cancer

Substanzen

C-Reactive ProteinProcalcitoninBiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Biomedical Research Group in Gynecology, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Breast Pathology Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Department of Gynecologic Oncology, IMED Hospital, Valencia, Spain.
  • Department of Gynecology, CEU Cardenal Herrera University, Valencia, Spain.
  • Department of Gynecologic Oncology, La Fe University Hospital, Valencia, Spain.

ORCID-Profile: José Luis Sánchez-Iglesias, Víctor Lago, Antoni Llueca, Úrsula Acosta, Antonio Gil-Moreno

Förderung

  • Fundació Institut de Recerca Hospital Universitari Vall d'Hebron
  • Fundació Institut de Recerca Hospital Universitari Vall d’Hebron

Zitieren

APA

Sánchez-Iglesias, J. L., Morales-Coma, C., Minig, L., Lago, V., Domingo, S., Mancebo, G., Siegrist, J., Fidalgo García, M. S., Llueca, A., Serra, A., Cobas Lozano, P., Lekuona Artola, A., Gómez-Hidalgo, N. R., Acosta, Ú., Ferrer-Costa, R., Bradbury, M., Pérez-Benavente, A., Gil-Moreno, A., & SEGO Spain‐GOG Group (2024). Procalcitonin and C‐reactive protein as early markers of anastomotic leakage in intestinal resections for advanced ovarian cancer ( EDMOCS ). Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14834

Vancouver

Sánchez-Iglesias JL, Morales-Coma C, Minig L, Lago V, Domingo S, Mancebo G, et al. Procalcitonin and C‐reactive protein as early markers of anastomotic leakage in intestinal resections for advanced ovarian cancer ( EDMOCS ). Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14834

BibTeX
@article{SnchezIglesias2024,
  author = {Sánchez-Iglesias, José Luis and Morales-Coma, Clara and Minig, Lucas and Lago, Víctor and Domingo, Santiago and Mancebo, Gemma and Siegrist, Jaime and Fidalgo García, María Soledad and Llueca, Antoni and Serra, Anna and Cobas Lozano, Paloma and Lekuona Artola, Arantza and Gómez-Hidalgo, Natalia R and Acosta, Úrsula and Ferrer-Costa, Roser and Bradbury, Melissa and Pérez-Benavente, Assumpció and Gil-Moreno, Antonio and SEGO Spain‐GOG Group, SEGO Spain‐GOG Group},
  title = {Procalcitonin and C‐reactive protein as early markers of anastomotic leakage in intestinal resections for advanced ovarian cancer ( EDMOCS )},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14834}
}
Kostenlos starten →